Dr. Paul Joseph Giorlando

M.D. | Pediatrics | Male

Dr. Paul Joseph Giorlando, M.D. is a Baton Rouge, Louisiana based Pediatric doctor with medical specialization in General Pediatrics. Current practice location of Dr. Paul Joseph Giorlando is 8415 Goodwood Blvd, Suite 100, Baton Rouge, Louisiana - 70806-7851. He can be contacted on phone at 225-765-5633 and fax number 225-765-5634. Dr. Paul Joseph Giorlando is a sole proprietor of his business.
NPI number (Unique professional ID) for Dr. Paul Joseph Giorlando is 1578546511 which was assigned by NPPES on 23 Nov, 2005 and it was last updated on 08 Jan, 2021. Dr. Paul Joseph Giorlando license number is 015670 for Pediatrics (208000000X) in Louisiana.
Dr. Paul Joseph Giorlando is a pediatrician who is concerned with the physical, emotional and social health of children from birth to young adulthood. Care encompasses a broad spectrum of health services ranging from preventive healthcare to the diagnosis and treatment of acute and chronic diseases. A pediatrician deals with biological, social and environmental influences on the developing child, and with the impact of disease and dysfunction on development.
Complete Profile:
Dr. Paul Joseph Giorlando basic information including his official name, gender, specialization, credentials etc. are as mentioned below.
Specialization :Pediatrics
Provider Name :Dr. Paul Joseph Giorlando
Credential :M.D.
Gender :Male
Business Address:
Dr. Paul Joseph Giorlando address, contact phone number and fax are as below. Patients can directly walkin to the clinic or can call on the below given phone number for appointment.
Primary Address :8415 Goodwood Blvd, Suite 100
Baton Rouge, LA, 70806-7851
United States
Phone Number :225-765-5633
Fax Number :225-765-5634
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number : 1578546511
NPI Entity Type : Individual
First Enrolment Date : 23 Nov, 2005
Last Updated On : 08 Jan, 2021
Licenses and Specialities:
Physicians/Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Paul Joseph Giorlando are as mentioned. Primary taxonomy code for Dr. Paul Joseph Giorlando, M.D. is 208000000X (Pediatrics).
Taxonomy Code SpecialityPrimaryLicense No.State
208000000XPediatricsYes015670LA
Legacy Identifiers:
Other legacy medical identifiers of Dr. Paul Joseph Giorlando such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned below.
IdentifierIdentifier TypeStateIssuer
1927619MEDICAIDLA
Endpoints:
Endpoints provide a simple, secure, scalable, and standards-based way for participants to send authenticated, encrypted health information directly to known, trusted recipients over the Internet. It is used by EHR systems (Electronic Health Records).
Endpoint TypeEndpointAffiliationUseContentAddress
DIRECT
(Direct Messaging Address)
pgiorlando2654@direct.casso.us.com

FMOLHS-Epic
No affiliationDIRECT
Direct
OTHER
Other
pgiorlando2654@direct.casso.us.com
8415 GOODWOOD BLVD, SUITE 100
BATON ROUGE, LA, 70806-7851
United States
FHIR
(FHIR URL)
https://epicproxy.et0830.epichosted.com/FHIRProxy/api/FHIR/DSTU2/

FMOLHS FHIR URL
No affiliationOTHER
Other
FHIR API
OTHER
Other
C-CDA
8415 GOODWOOD BLVD, SUITE 100
BATON ROUGE, LA, 70806-7851
United States
Mailing Address:
Mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned business address only.
Mailing Address :8415 Goodwood Blvd, Suite 100
Baton Rouge, LA, 70806-7851
United States
Phone Number :225-765-5633
Fax Number :225-765-5634
Business Location:
Patients can refer following map for directions to Dr. Paul Joseph Giorlando practice address. Don't forget to take prior appointment before visiting.

** Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 January, 2024.